DOI: 10.1055/s-00000069

Seminars in Liver Disease


Ma X, Lalezari J, Nguyen T. , et al.
Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients.

J Hepatol 2019;
70: e130-e131

Download Bibliographical Data

Search in: